Life Sciences and Emerging Growth Businesses
Q2 2026 sales were $294 million, down 15% year over year.
The numbers
Net sales$294 millionQ2 2026 · -15% year over year · source ↗
What it is
Labware, cell culture products and other emerging-growth businesses. Reported as a group from Q1 2026.
Why it matters to the stock. This small segment is currently shrinking, so it is a drag on total growth rather than a driver.
News
No stories tagged to this project yet.